INCY: Incyte Corporation

68.94 USD 0.18 (0.26%)

セクター: ヘルスケアベース: US Dollar 利益通貨: US Dollar

INCYの今日の為替レートは、-0.26%変化しました。日中、通貨は1あたり68.84の安値と69.64の高値で取引されました。

Incyte Corporationダイナミクスに従います。リアルタイムの相場は、市場の変化に迅速に対応するのに役立ちます。異なる時間枠に切り替えることで、為替レートの傾向とダイナミクスを分、時間、日、週、月単位で監視できます。この情報を使用して、市場の変化を予測し、十分な情報に基づいて取引を決定してください。

全画面チャート

INCY News

Zacks 13:40 Is BrightSpring Health Services, Inc. (BTSG) Outperforming Other Medical Stocks This Year?
Zacks 15:40 INCY or TECH: Which Is the Better Value Stock Right Now?
Investing 14:32 Incyte stock price target raised to $62 from $61 at UBS on sales outlook
Investing 07:12 Goldman Sachs initiates coverage on Syndax stock with Buy rating
Seeking Alpha 10:11 Incyte: New CEO Brings A New Possible Outcome (NASDAQ:INCY)
Investing 09:56 BTIG reiterates Buy rating on VYNE Therapeutics stock ahead of vitiligo trial data
Seeking Alpha 12:00 S&P 500 Stocks: Screening For Long-Term Winners, My List Of 13 (SPX)
Investor's Business Daily 07:00 Incyte Stock Gets Relative Strength Rating Lift
Investing 17:14 Incyte stock rises as William Blair reiterates market perform rating
Investing 15:25 Citi reiterates buy rating on Incyte stock amid CEO transition
Investor's Business Daily 13:11 Incyte's New CEO Is A Dealmaking Machine. Will He Bring That Fervor To His New Role?
Investing 13:04 Syndax Pharmaceuticals director William Meury resigns following new CEO role at Incyte
Investing 11:57 Incyte stock rises after appointing Bill Meury as new CEO
Investing 11:34 Incyte names Bill Meury as new CEO as Hervé Hoppenot retires
Investing 16:49 Incyte stock falls after FDA extends review of pediatric eczema cream
Seeking Alpha 13:18 Genmab: This Is Anything But A Value Trap, Yet It Is Currently Priced As One (NASDAQ:GMAB)
Investing 20:38 FDA extends review period for Incyte’s atopic dermatitis cream
Investing 19:45 FDA approves Monjuvi combination therapy for follicular lymphoma
Seeking Alpha 01:14 Tracking Baker Brothers Portfolio – Q1 2025 Update
Benzinga 11:52 Incyte's Experimental Therapy Shows Platelet Normalization And Safety In Rare Blood Cancer Trials Across Doses - Incyte (NASDAQ:INCY)
Investing 10:58 Incyte stock rating reiterated by Oppenheimer on promising cancer drug data
Benzinga 10:00 Why Incyte Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket - Battalion Oil (AMEX:BATL), AIRO Group Holdings (NASDAQ:AIRO)
Investing 09:46 Jefferies raises Incyte stock price target on promising drug data
Investing 07:55 Incyte stock rating upgraded by Stifel on promising blood disorder drug

1日のレンジ

68.84 69.64

1年のレンジ

53.56 83.95

以前の終値: 69.23
始値: 69.12

買値: 68.94
買値: 69.24

安値: 68.84
高値: 69.64

出来高: 1.815 K

1日の変化: -0.26%
1ヶ月の変化: 2.67%

6ヶ月の変化: -6.47%
1年の変化: 5.48%

17 7月, 木曜日